Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease
- 1 February 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 205 (3) , 313-323
Abstract
Rationale: Multiple studies have demonstrated an increased risk of chronic obstructive pulmonary disease (COPD) in heterozygous carriers of the AAT (alpha-1 antitrypsin) Z allele. However, it is not known if MZ subjects with COPD are phenotypically different from noncarriers (MM genotype) with COPD. Objectives: To assess if MZ subjects with COPD have different clinical features compared with MM subjects with COPD. Methods: Genotypes of SERPINA1 were ascertained by using whole-genome sequencing data in three independent studies. We compared outcomes between MM subjects with COPD and MZ subjects with COPD in each study and combined the results in a meta-analysis. We performed longitudinal and survival analyses to compare outcomes in MM and MZ subjects with COPD over time. Measurements and Main Results: We included 290 MZ subjects with COPD and 6,184 MM subjects with COPD across the three studies. MZ subjects had a lower FEV1% predicted and greater quantitative emphysema on chest computed tomography scans compared with MM subjects. In a meta-analysis, the FEV1 was 3.9% lower (95% confidence interval [CI], −6.55% to −1.26%) and emphysema (the percentage of lung attenuation areas <−950 HU) was 4.14% greater (95% CI, 1.44% to 6.84%) in MZ subjects. We found one gene, PGF (placental growth factor), to be differentially expressed in lung tissue from one study between MZ subjects and MM subjects. Conclusions: Carriers of the AAT Z allele (those who were MZ heterozygous) with COPD had lower lung function and more emphysema than MM subjects with COPD. Taken with the subtle differences in gene expression between the two groups, our findings suggest that MZ subjects represent an endotype of COPD.Keywords
Funding Information
- NIH (R01HL130512)
- NIH (R01HL125583)
- NIH (U01HL089856)
- NIH (U01HL089897)
- NIH (R01HL124233)
- NIH (R01HL147326)
- NIH (T32HL007427)
- Alpha-1 Foundation
- NIH (R01HL130512)
- NIH (R01HL125583)
- NIH (U01HL089856)
- NIH (U01HL089897)
- NIH (R01HL124233)
- NIH (R01HL147326)
- NIH (T32HL007427)
- Alpha-1 Foundation
This publication has 39 references indexed in Scilit:
- SERPINA1 PiZ and PiS Heterozygotes and Lung Function Decline in the SAPALDIA CohortPLOS ONE, 2012
- Protein Misfolding and Obstructive Lung DiseaseProceedings of the American Thoracic Society, 2010
- Genetic Epidemiology of COPD (COPDGene) Study DesignCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)European Respiratory Journal, 2008
- Increased expression of placenta growth factor in COPDThorax, 2008
- Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPDEuropean Respiratory Journal, 2007
- Chronic obstructive pulmonary disease in 1-antitrypsin PI MZ heterozygotes: a meta-analysisThorax, 2004
- A Longitudinal Study of α1-Antitrypsin Phenotypes and Decline in FEV1 in a Community PopulationChest, 2003
- The mechanism of Z α1-antitrypsin accumulation in the liverNature, 1992
- Pulmonary vascular structure and function in chronic obstructive pulmonary disease.Thorax, 1988